Sawcer SJ - Search Results

1

IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).

Jones JL, Phuah CL, Cox AL, Thompson SA, Ban M, Shawcross J, Walton A, Sawcer SJ, Compston A, Coles AJ. Jones JL, et al. Among authors: sawcer sj. J Clin Invest. 2009 Jul;119(7):2052-61. doi: 10.1172/JCI37878. Epub 2009 Jun 22. J Clin Invest. 2009. PMID: 19546505 Free PMC article.

2

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22.

Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A. Sawcer S, et al. Nat Genet. 1996 Aug;13(4):464-8. doi: 10.1038/ng0896-464. Nat Genet. 1996. PMID: 8696343

3

Empirical genomewide significance levels established by whole genome simulations.

Sawcer S, Jones HB, Judge D, Visser F, Compston A, Goodfellow PN, Clayton D. Sawcer S, et al. Genet Epidemiol. 1997;14(3):223-9. doi: 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6. Genet Epidemiol. 1997. PMID: 9181352

4

The genetic analysis of multiple sclerosis.

Sawcer S, Goodfellow PN, Compston A. Sawcer S, et al. Trends Genet. 1997 Jun;13(6):234-9. doi: 10.1016/S0168-9525(97)01140-2. Trends Genet. 1997. PMID: 9196329 Review.

5

The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen.

Chataway J, Feakes R, Coraddu F, Gray J, Deans J, Fraser M, Robertson N, Broadley S, Jones H, Clayton D, Goodfellow P, Sawcer S, Compston A. Chataway J, et al. Brain. 1998 Oct;121 ( Pt 10):1869-87. doi: 10.1093/brain/121.10.1869. Brain. 1998. PMID: 9798743 Review.

6

HLA typing in the United Kingdom multiple sclerosis genome screen.

Coraddu F, Sawcer S, Feakes R, Chataway J, Broadley S, Jones HB, Clayton D, Gray J, Smith S, Taylor C, Goodfellow PN, Compston A. Coraddu F, et al. Neurogenetics. 1998 Dec;2(1):24-33. doi: 10.1007/s100480050048. Neurogenetics. 1998. PMID: 9933297

7

Exploring the dense mapping of a region of potential linkage in complex disease: an example in multiple sclerosis.

Feakes R, Sawcer S, Chataway J, Coraddu F, Broadley S, Gray J, Jones HB, Clayton D, Goodfellow PN, Compston A. Feakes R, et al. Genet Epidemiol. 1999;17(1):51-63. doi: 10.1002/(SICI)1098-2272(1999)17:1<51::AID-GEPI4>3.0.CO;2-V. Genet Epidemiol. 1999. PMID: 10323184

8

Evidence that allelic variants of the spinocerebellar ataxia type 2 gene influence susceptibility to multiple sclerosis.

Chataway J, Sawcer S, Coraddu F, Feakes R, Broadley S, Jones HB, Clayton D, Gray J, Goodfellow PN, Compston A. Chataway J, et al. Neurogenetics. 1999 Apr;2(2):91-6. doi: 10.1007/s100480050058. Neurogenetics. 1999. PMID: 10369884

9

A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis.

Chataway J, Sawcer S, Feakes R, Coraddu F, Broadley S, Jones HB, Clayton D, Gray J, Goodfellow PN, Compston A. Chataway J, et al. J Neuroimmunol. 1999 Aug 3;98(2):208-13. doi: 10.1016/s0165-5728(99)00089-2. J Neuroimmunol. 1999. PMID: 10430054

10

No evidence for association of multiple sclerosis with the complement factors C6 and C7.

Chataway J, Sawcer S, Sherman D, Hobart M, Fernie B, Coraddu F, Feakes R, Broadley S, Gray J, Jones HB, Clayton D, Goodfellow PN, Compston A. Chataway J, et al. J Neuroimmunol. 1999 Sep 1;99(1):150-6. doi: 10.1016/s0165-5728(99)00054-5. J Neuroimmunol. 1999. PMID: 10496188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters